Won Hollywood Gold Cup (G1,Hol,10F), Alysheba S. (G3,CD,)
Foaled March 27, 2007.
Broke maiden January 30, 2010 at Gulfstream Park (8 furlongs, MdSpWt, 1:37, 77 Beyer) Retired due to a strained tendon, July 2011.
( CLOSE ) STEPHEN GOT EVEN (USA)
b. 1996 . INDY (USA)
dkb/br. 1989 [IC] SEATTLE SLEW (USA)
dkb/br. 1974 [BC] BOLD REASONING (USA)
dkb/br. 1968 BOLDNESIAN (USA) b. 1963 REASON TO EARN (USA) b. 1963 MY CHARMER (USA) *
b. 1969 POKER (USA) b. 1963 FAIR CHARMER (USA) ch. 1959 WEEKEND SURPRISE (USA) *
b. 1980 SECRETARIAT (USA)
ch. 1970 [IC] BOLD RULER (USA) dkb/br. 1954 [BI] SOMETHINGROYAL (USA) b. 1952 * LASSIE DEAR (USA) *
b. 1974 BUCKPASSER (USA) b. 1963 [C] GAY MISSILE (USA) b. 1967 IMMERSE (USA)
b. 1988 COXS RIDGE (USA)
b. 1974 BEST TURN (USA)
br. 1966 [C] TURN-TO (IRE) b. 1951 [BI] SWEET CLEMENTINE (USA) b. 1960 OUR MARTHA (USA)
ch. 1961 BALLYDONNELL (GB) ch. 1952 CORDAY (USA) ch. 1946 BARONESS DIRECT (USA)
b. 1981 BLUSHING GROOM (FR)
ch. 1974 [BC] RED GOD (USA) ch. 1954 RUNAWAY BRIDE (GB) b. 1962 AVUM (USA)
dkb/br. 1973 UMBRELLA FELLA (USA) b. 1962 AVIE (USA) b. 1963 RUN SARAH RUN (USA)
dkb/br. 2000 SMART STRIKE (CAN)
b. 1992 [IC] MR. PROSPECTOR (USA)
b. 1970 [BC] RAISE A NATIVE (USA)
ch. 1961 [B] NATIVE DANCER (USA) gr. 1950 [IC] RAISE YOU (USA) ch. 1946 * GOLD DIGGER (USA) *
b. 1962 NASHUA (USA) b. 1952 [IC] SEQUENCE (USA) b. 1946 CLASSY 'N SMART (CAN) *
b. 1981 SMARTEN (USA)
dkb/br. 1976 CYANE (USA) b. 1959 SMARTAIRE (USA) dkb/br. 1962 * NO CLASS (CAN) *
b. 1974 NODOUBLE (USA) ch. 1965 [CP] CLASSY QUILLO (CAN) dkb/br. 1969 * BREECH (USA)
gr. 1984 RELAUNCH (USA)
gr. 1976 IN REALITY (USA)
b. 1964 [BC] INTENTIONALLY (USA) blk. 1956 [BI] MY DEAR GIRL (USA) ch. 1957 * FOGGY NOTE (USA) *
gr. 1965 THE AXE (USA) gr. 1958 SILVER SONG (USA) gr. 1957 SCATTER PLAN (USA)
b. 1968 QUADRANGLE (USA)
b. 1961 COHOES (USA) b. 1954 TAP DAY (USA) b. 1947 PURDAH (USA)
b. 1954 NASRULLAH (GB) b. 1940 [B] UVIRA (GB) b. 1938 *
Clostridium difficile associated diarrhea (CDAD) has been reported with almost all antibiotics and may potentially be life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea following cephalosporin therapy. Mild cases generally improve with discontinuation of the drug, while severe cases may require supportive therapy and treatment with an antimicrobial agent effective against C difficile. Hypertoxin producing strains of C difficile cause increased morbidity and mortality; these infections can be resistant to antimicrobial treatment and may necessitate colectomy.
Cephalosporins may be associated with a fall in prothrombin activity. Risk factors include renal or hepatic impairment, poor nutritional state, a protracted course of antimicrobial therapy, and chronic anticoagulation therapy. Prothrombin times should be monitored and vitamin K therapy initiated if indicated.
Serious and occasionally fatal hypersensitivity reactions have been reported with antibiotics. The drug should be discontinued immediately at the first appearance of a skin rash or other signs of hypersensitivity. Severe, acute hypersensitivity reactions may require treatment with epinephrine and other resuscitative measures including oxygen, intravenous fluids, antihistamines, corticosteroids, cardiovascular support and airway management as clinically indicated.
Dosage adjustments are recommended in patients with renal insufficiency. Some cephalosporins have been associated with seizures in renally impaired patients with elevated serum concentrations. The drug should be discontinued if seizures occur. Nephrotoxicity has occurred with concomitant cephalosporins and aminoglycosides or potent diuretics. Renal function should be monitored, especially in elderly patients.